ScholarIQanswers from OpenAlex & ORCID
Min Liu
ResearcherPublications, citations & collaboration network
Min Liu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Min Liu have?
ScholarIQindexed works
Min Liu has 408 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Min Liu have?
ScholarIQcitation count
Min Liu has 9,920 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Min Liu?
ScholarIQh-index
Min Liu has an h-index of 52 in OpenAlex.
What is the i10-index of Min Liu?
ScholarIQi10-index
Min Liu has an i10-index of 217 in OpenAlex.
What is the ORCID of Min Liu?
ScholarIQorcid
The ORCID for Min Liu is on the source record.
What is the OpenAlex record for Min Liu?
ScholarIQopenalex
The OpenAlex for Min Liu is on the source record.
What are the most-cited papers on Min Liu?
ScholarIQmost cited works
Large-scale transcriptome comparison reveals distinct gene activations in wheat responding to stripe rust and powdery mildew
Hong Zhang, Yongzheng Yang, Changyou Wang, Min Liu, Hao Li, Ying Fu, Yajuan Wang, Yingbin Nie, Xinlun Liu, Wanquan Ji
New insights into the cellular responses to iron nanoparticles in Capsicum annuum
Junxia Yuan, Yu Chen, Huasheng Li, Jinying Lu, Hui Zhao, Min Liu, Galina Semenovna Nechitaylo, Glushchenko Nn
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis
Lan Fang, Hongqi Teng, Yilin Wang, Guanghong Liao, Linjun Weng, Yaxu Li, Xinbo Wang, Jiali Jin, Chenchen Jiao, Lei Chen, Xiao-Ping Peng, Jiayu Chen, Yongzhi Yang, Houqin Fang, Dongyan Han, Cheng Li, Xueling Jin, Shihao Zhang, Zhongchen Liu, Min Liu, Qing Wei, Lujian Liao, Xin Ge, Bin Zhao, Dawang Zhou, Huanlong Qin, Jun Zhou, Ping Wang
MicroRNA‐9 inhibits ovarian cancer cell growth through regulation of NF‐κB1
Limin Guo, Yong Pu, Zhe Han, Tao Liu, Yixuan Li, Min Liu, Xin Li, Hua Tang
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
Shijun Ma, Yue Zhao, Wee Chyan Lee, L.S. Ong, Puay Leng Lee, Zemin Jiang, Gokce Oguz, Zhitong Niu, Min Liu, Jian Yuan Goh, Wenyu Wang, Matías A. Bustos, Sidse Ehmsen, Adaikalavan Ramasamy, Dave S.�B. Hoon, Henrik J. Ditzel, Ern Yu Tan, Qingfeng Chen, Qiang Yu